------------------------------
                                                           OMB APPROVAL
                                                  ------------------------------
                                                  OMB Number          
                                                  Expires:        
                                                  Estimated average burden
                                                  hours per response ....... 0.5
                                                  ------------------------------


                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C.  20549

                                 SCHEDULE 13G
                                (Rule 13d-102)


             INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
           TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED
                           PURSUANT TO RULE 13d-2(b)*


                          QLT Photo Therapeutics Inc.
                                (Name of Issuer)


                                  Common Stock
                         (Title of Class of Securities)


                                   746927102
                                 (CUSIP Number)


                               December 31, 1998
            (Date of Event Which Requires Filing of this Statement)


     Check the  appropriate  box to  designate  the rule  pursuant to which this
Schedule is filed:

          [X]  Rule 13d-1(b)

          [_]  Rule 13d-1(c)

          [_]  Rule 13d-1(d)

- ----------
*    The  remainder  of this  cover  page  shall be filled  out for a  reporting
     person's  initial  filing on this form with respect to the subject class of
     securities,  and for any subsequent amendment containing  information which
     would alter the disclosures provided in a prior cover page.

     The  information  required in the remainder of this cover page shall not be
deemed to be "filed"  for the purpose of Section 18 of the  Securities  Exchange
Act of 1934 or otherwise  subject to the  liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).



<PAGE>

CUSIP No.                             13G                    Page    of    Pages


________________________________________________________________________________
1.   NAME OF REPORTING PERSONS
     I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

     TAL Global Asset Management Inc.

________________________________________________________________________________
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                 (a)  [_]
                                                                 (b)  [_]

________________________________________________________________________________
3.   SEC USE ONLY



________________________________________________________________________________
4.   CITIZENSHIP OR PLACE OF ORGANIZATION

     Canada

________________________________________________________________________________
  NUMBER OF    5.   SOLE VOTING POWER
                    
   SHARES           1,599,975
               _________________________________________________________________
BENEFICIALLY   6.   SHARED VOTING POWER
                    
  OWNED BY          N/A
               _________________________________________________________________
    EACH       7.   SOLE DISPOSITIVE POWER
                    
  REPORTING         1,638,590
               _________________________________________________________________
   PERSON      8.   SHARED DISPOSITIVE POWER
                    
    WITH            N/A
________________________________________________________________________________
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     1,648,365

________________________________________________________________________________
10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

                                                                          [_]

________________________________________________________________________________
11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     6.1%

________________________________________________________________________________
12.  TYPE OF REPORTING PERSON*

     IA

________________________________________________________________________________
                     *SEE INSTRUCTIONS BEFORE FILLING OUT!


<PAGE>


CUSIP No.                             13G                    Page    of    Pages


________________________________________________________________________________
Item 1(a).  Name of Issuer:

            QLT Photo Therapeutics Inc.

________________________________________________________________________________
Item 1(b).  Address of Issuer's Principal Executive Offices:

            200, 520 West 6th Avenue
            Vancouver, British Columbia V5Z 4H5
________________________________________________________________________________
Item 2(a).  Name of Person Filing:

            TAL Global Asset Management Inc.

________________________________________________________________________________
Item 2(b).  Address of Principal Business Office, or if None, Residence:

            1000 de la Gauchetiere West, Suite 3100
            Montreal, Quebec, Canada H3B 4W5
________________________________________________________________________________
Item 2(c).  Citizenship:

            Canada

________________________________________________________________________________
Item 2(d).  Title of Class of Securities:

            Common Stock

________________________________________________________________________________
Item 2(e).  CUSIP Number:

            746927102

________________________________________________________________________________
Item 3.     If This Statement  is Filed  Pursuant to  Rule 13d-1(b), or 13d-2(b)
            or (c), Check Whether the Person Filing is a:

     (a)  [_]  Broker or dealer registered under Section 15 of the Exchange Act.

     (b)  [_]  Bank as defined in Section 3(a)(6) of the Exchange Act.

     (c)  [_]  Insurance  company as defined in Section 3(a)(19) of the Exchange
               Act.

     (d)  [_]  Investment  company  registered under Section 8 of the Investment
               Company Act.

     (e)  [X]  An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

     (f)  [_]  An employee  benefit plan or endowment  fund in  accordance  with
               Rule 13d-1(b)(1)(ii)(F);

     (g)  [_]  A parent  holding  company or control  person in accordance  with
               Rule 13d-1(b)(1)(ii)(G);

     (h)  [_]  A savings  association  as defined in Section 3(b) of the Federal
               Deposit Insurance Act;

     (i)  [_]  A  church  plan  that  is  excluded  from  the  definition  of an
               investment  company  under  Section  3(c)(14)  of the  Investment
               Company Act;

     (j)  [_]  Group, in accordance with Rule 13d-1(b)(1)(ii)(J).


     If this statement is filed pursuant to Rule 13d-1(c), check this box.   [_]



<PAGE>


CUSIP No.                             13G                    Page    of    Pages


Item 4.  Ownership.

     Provide  the  following  information  regarding  the  aggregate  number and
percentage of the class of securities of the issuer identified in Item 1.

     (a)  Amount beneficially owned: 1,648,365

     (b)  Percent of class: 6.1%

     (c)  Number of shares as to which such person has:

          (i)   Sole power to vote or to direct the vote 1,599,975,

          (ii)  Shared power to vote or to direct the vote N/A,

          (iii) Sole power to dispose or to direct the disposition of 1,638,590,

          (iv)  Shared power to dispose or to direct the disposition of N/A


________________________________________________________________________________
Item 5.  Ownership of Five Percent or Less of a Class.

          N/A


________________________________________________________________________________
Item 6.  Ownership of More Than Five Percent on Behalf of Another Person.

         Various  persons  have the right to  receive or the power to direct the
         receipt of dividends from, or the proceeds from the sale of, the common
         stock of QLT Photo  Therapeutics  Inc. No one person's  interest in the
         common stock of QLT Photo  Therapeutics  Inc. is more than five percent
         of the total outstanding common stock.

________________________________________________________________________________
Item 7.  Identification and Classification of the Subsidiary Which Acquired the
         Security Being Reported on by the Parent Holding Company.

         N/A

________________________________________________________________________________
Item 8.  Identification and Classification of Members of the Group.

         N/A

________________________________________________________________________________
Item 9.  Notice of Dissolution of Group.

         N/A

________________________________________________________________________________
Item 10.  Certifications.

          By  signing  below I certify  that,  to the best of my  knowledge  and
          belief, the securities referred to above were acquired and are held in
          the ordinary course of business and were not acquired and not held for
          the  purpose  of or with the effect of  changing  or  influencing  the
          control of the issuer of the  securities and were not acquired and are
          not held in  connection  with or as a participant  in any  transaction
          having such purpose or effect.



<PAGE>


                                    SIGNATURE

     After  reasonable  inquiry and to the best of my  knowledge  and belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.


                                                   February 12, 1999
                                                        (Date)


                                                 /s/ Assunta DiLorenzo
                                        ----------------------------------------
                                                      (Signature)


                                              Vice President Legal Affairs &
                                                   Corporate Secretary
                                                      (Name/Title)



Note.  Schedules  filed in paper format shall include a signed original and five
copies of the  schedule,  including  all  exhibits.  See Rule 13d-7(b) for other
parties for whom copies are to be sent.

Attention.  Intentional  misstatements  or omissions of fact constitute  federal
criminal violations (see 18 U.S.C. 1001).